← European Medicine Shortage Tracker · all medicines

Dioflav shortage — availability across Europe

Name: European Medicine Shortage Tracker dataset
Creator: MobiDoctor
License: https://creativecommons.org/licenses/by/4.0/

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED

Dr. Chrysoula I. Liakou MD, PhD

Internal Medicine Specialist
Cancer Immunology Researcher

Reviewed 30 July 2026 · next review due 30 January 2027

Dioflav currently has availability issues reported in 1 European register: Spain.

Shortage ATC — · also listed as: DIOFLAV · data refreshed 13 September 2026

Key facts

As of 13 September 2026, Dioflav has active availability issues in 1 of 9 tracked European registers.
Registers reporting issues: Spain.
Latest expected-resolution date on file: 2026-10-30.
Longest-running open report: since 2026-06-21 (3 months, Spain).
Data source: 1 official medicines-agency register, refreshed daily.

As of 13 September 2026, 1 of the 9 tracked registers list current availability issues for Dioflav, covering 1 affected product presentation. The longest-running open report was filed in Spain on 2026-06-21 and has now been open for about 3 months. The furthest expected-resolution date currently on file is 2026-10-30; the earliest is 2026-10-30.

Where	Status & products	Since	Expected end	Reason / alternatives	Source
🇪🇸 Spain	Shortage DIOFLAV 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos	2026-06-21	2026-10-30	—	register ↗

Full report history (1 register entry)

Every individual register entry for Dioflav in the tracked sources, newest first — including resolved and discontinued reports.

Reg.	Product	Status	Reported	Expected end	Stated reason
🇪🇸 ES	DIOFLAV 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos	Shortage	2026-06-21	2026-10-30

Frequently asked

Is Dioflav currently in shortage in Europe?

Yes. As of 13 September 2026, availability issues are reported in: Spain. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Dioflav shortage expected to end?

Agency prognoses on file range from 2026-10-30 to 2026-10-30. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Where does this Dioflav availability data come from?

Directly from the official medicines-agency register that lists Dioflav: AEMPS CIMA (Spain). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Dioflav — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/dioflav/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Dioflav availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/dioflav/">Dioflav shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>

Cite: “Dioflav: availability status across 1 European registers — European Medicine Shortage Tracker (MobiDoctor), 13 September 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.